mTOR is an oncogene and constitutively activated PI3K/Akt signaling pathway was observed in almost every types of tumors (Populo et al., 2012; Xie et al., 2016; Wang et al., 2017) including NSCLC (Gridelli et al., 2008). Here, MTOR is linked to non-small cell lung carcinoma.